Altre lingue Recordati

Azioni

REC

IT0003828271

Prodotti farmaceutici

Mercato chiuso - Borsa Italiana Altri mercati azionari 17:44:59 06/12/2024			Variaz. 5gg	Var. 1 gen.
51,95 ^EUR	+1,07%		+0,78%	+6,39%

04/12	Borsa : Europa chiude positiva ma guarda a Francia, a Milano (+0,75%) brilla Campari -2-	DJ
04/12	Mib unico in verde; focus su voto francese	AN

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

RECORDATI : COMPLETES THE ACQUISITION OF THE GLOBAL RIGHTS TO ENJAYMO®	29/11
Wall Street creuse l'écart avant Thanksgiving	27/11
En Direct des Marchés : Carrefour rétropédale, Teleperformance investit, Stellantis dans le dur	27/11
Recordati investor CVC taps up potential buyers of drugs group, rival says	26/11
RECORDATI: UPDATE ON THE EXECUTION OF THE SHARE BUY-BACK PROGRAM. CONCLUSION OF THE PROGRAM INITIATED ON 10th MAY 2024.	11/11
RECORDATI: SHARE BUY-BACK PROGRAM TO SERVICE THE STOCK OPTION/PERFORMANCE SHARES PLANS	11/11
Recordati : First nine months 2024	11/11
Trump makes Wall Street shine and depresses Europe	11/11
Trump fait briller Wall Street et déprime l'Europe	11/11
En Direct des Marchés : Stellantis freine avec Leapmotor, Continental avertit, Tesla puissance 1000	11/11
Italy's Recordati sees no impact from potential US pharma tariffs	08/11
Global markets live: Airbnb, Motorola, Blackrock, P&G, Leonardo...	08/11
RECORDATI: CONTINUED DOUBLE DIGIT GROWTH IN THE FIRST NINE MONTHS OF 2024 REVENUE 12.0%, EBITDA 11.8%, ADJUSTED NET INCOME 9.5%	08/11
Recordati : Directors' report on the distribution of an interim dividend and interim financial statements at 30 June 2024	08/11
Recordati Industria Chimica e Farmaceutica S.p.A. Reports Earnings Results for the Nine Months Ended September 30, 2024	08/11
RECORDATI: CONTINUED DOUBLE-DIGIT GROWTH IN THE FIRST NINE MONTHS OF 2024 - REVENUE +12.0%, EBITDA(1) +11.8%, ADJUSTED NET INCOME(2) +9.5%	08/11
Le S&P500 se voit bien à 6000 points pour le weekend	08/11
En Direct des Marchés : Atos cherche des sous, Pinterest s'enfonce, Richemont fait le dos rond	08/11
Sanofi : cession d'un anti-anémique à l'italien Recordati	04/10
Actualización de las fuertes variaciones del día: DSV realiza una importante adquisición mientras los armadores caen	04/10
MIDDAY BRIEFING - Unternehmen und Märkte -2-	04/10
Les actions en mouvement : DSV réalise une acquisition majeure alors que les armateurs chutent	04/10
Recordati rachète à Sanofi des droits pour 825 millions de dollars	04/10
Recordati buys rights to rare immune disorder drug from Sanofi for $825 million	04/10
Recordati to Buy International Rights for Rare Blood Disease Drug from Sanofi	04/10

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

In prima pagina

Recordati: una mid-cap italiana con tutte le carte in regola

05 febbraio 2024 alle 13:35